The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.
<h4>Background</h4>In India as elsewhere, multi-drug resistance (MDR) poses a serious challenge in the control of tuberculosis (TB). The End TB strategy, recently approved by the world health assembly, aims to reduce TB deaths by 95% and new cases by 90% between 2015 and 2035. A key pill...
Saved in:
| Main Authors: | Kuldeep Singh Sachdeva, Neeraj Raizada, Radhey Shyam Gupta, Sreenivas Achuthan Nair, Claudia Denkinger, Chinnambedu Nainarappan Paramasivan, Shubhangi Kulsange, Rahul Thakur, Puneet Dewan, Catharina Boehme, Nimalan Arinaminpathy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0131438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis.
by: Sreenivas Achuthan Nair, et al.
Published: (2016-01-01) -
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.
by: Neeraj Raizada, et al.
Published: (2015-01-01) -
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
by: Neeraj Raizada, et al.
Published: (2014-01-01) -
Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.
by: Sunil Khaparde, et al.
Published: (2017-01-01) -
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
by: Kuldeep Singh Sachdeva, et al.
Published: (2015-01-01)